These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2158911)

  • 21. Plasma arginine-vasopressin levels during infusion of synthetic atrial natriuretic peptide on different sodium intakes in man.
    Gnädinger MP; Weidmann P; Rascher W; Lang RE; Hellmüller B; Uehlinger DE
    J Hypertens; 1986 Oct; 4(5):623-9. PubMed ID: 2947950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrial natriuretic peptide and urinary cyclic guanosine monophosphate in patients with chronic heart failure.
    Abraham WT; Hensen J; Kim JK; Dürr J; Lesnefsky EJ; Groves BM; Schrier RW
    J Am Soc Nephrol; 1992 Jun; 2(12):1697-703. PubMed ID: 1323337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific binding activities and cyclic GMP responses by atrial natriuretic polypeptide in kidney epithelial cell line (LLC-PK1).
    Inui K; Saito H; Matsukawa Y; Nakao K; Morii N; Imura H; Shimokura M; Kiso Y; Hori R
    Biochem Biophys Res Commun; 1985 Oct; 132(1):253-60. PubMed ID: 2415124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man.
    Fujita T; Ito Y; Noda H; Sato Y; Ando K; Kangawa K; Matsuo H
    J Clin Invest; 1987 Sep; 80(3):832-40. PubMed ID: 3040808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is atrial natriuretic peptide-guanosine 3',5' cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension?
    Sagnella GA; Singer DR; Markandu ND; Buckley MG; MacGregor GA
    J Hypertens; 1992 Apr; 10(4):349-54. PubMed ID: 1316400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
    Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
    Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial and brain natriuretic peptide in adrenal steroidogenesis.
    Nawata H; Ohashi M; Haji M; Takayanagi R; Higuchi K; Fujio N; Hashiguchi T; Ogo A; Nakao R; Ohnaka K
    J Steroid Biochem Mol Biol; 1991; 40(1-3):367-79. PubMed ID: 1659877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natriuretic and hypotensive effects of chronically administered alpha-human atrial natriuretic polypeptide in sodium-deplete or replete conscious spontaneously hypertensive rats.
    Kida O; Kondo K; Tanaka K
    J Hypertens Suppl; 1986 Dec; 4(6):S529-31. PubMed ID: 2956387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrogenous cyclic GMP production during NaCl loading and ANP infusion.
    Hirata Y; Fukui K; Hayakawa H; Namba S; Ishimitsu T; Sugimoto T; Kimura K; Matsuoka H; Sugimoto T
    Jpn Heart J; 1990 Nov; 31(6):809-16. PubMed ID: 1964701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood levels and renal effects of atrial natriuretic peptide in normal man.
    Weidmann P; Hasler L; Gnädinger MP; Lang RE; Uehlinger DE; Shaw S; Rascher W; Reubi FC
    J Clin Invest; 1986 Mar; 77(3):734-42. PubMed ID: 2936762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intranasal administration of atrial natriuretic hormone on spontaneously hypertensive rats.
    Shionoiri H; Yasuda G; Oda H; Gotoh E; Ito T; Kaneko Y
    Endocrinol Jpn; 1987 Jun; 34(3):443-8. PubMed ID: 2958274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
    J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dopamine receptor antagonist haloperidol blocks natriuretic but not hypotensive effects of the atrial natriuretic factor.
    Hansell P; Fasching A; Sjöquist M; Andén NE; Ulfendahl HR
    Acta Physiol Scand; 1987 Jul; 130(3):401-7. PubMed ID: 2957892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension.
    Richards AM; Crozier IG; Holmes SJ; Espiner EA; Yandle TG; Frampton C
    J Hypertens; 1993 Feb; 11(2):163-70. PubMed ID: 8385176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of the natriuretic effects of exogenous atrial natriuretic peptide in animals with total artificial hearts.
    Mabuchi K; Hayakawa H; Hirata Y; Iizuka M; Imachi K; Chinzei T; Nozawa H; Abe Y; Yonezawa T; Suzukawa M
    ASAIO Trans; 1991; 37(3):M214-6. PubMed ID: 1661120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose infusion of atrial natriuretic factor in mild essential hypertension.
    Tonolo G; Richards AM; Manunta P; Troffa C; Pazzola A; Madeddu P; Towrie A; Fraser R; Glorioso N
    Circulation; 1989 Oct; 80(4):893-902. PubMed ID: 2529059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW; Canepa-Anson R; Armstrong PW
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of intravenously administered beta-human atrial natriuretic polypeptide in humans.
    Itoh H; Nakao K; Mukoyama M; Shiono S; Morii N; Sugawara A; Yamada T; Saito Y; Arai H; Hosoda K
    Hypertension; 1988 Jun; 11(6 Pt 2):697-702. PubMed ID: 2968953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.